Kinetic and structural insights into the mechanism of AMPylation by VopS Fic domain.
The bacterial pathogen Vibrio parahemeolyticus manipulates host signaling pathways during infections by injecting type III effectors into the cytoplasm of the target cell. One of these effectors, VopS, blocks actin assembly by AMPylation of a conserved threonine residue in the switch 1 region of Rho GTPases. The modified GTPases are no longer able to interact with downstream effectors due to steric hindrance by the covalently linked AMP moiety. Herein we analyze the structure of VopS and its evolutionarily conserved catalytic residues. Steady-state analysis of VopS mutants provides kinetic understanding on the functional role of each residue for AMPylation activity by the Fic domain. Further mechanistic analysis of VopS with its two substrates, ATP and Cdc42, demonstrates that VopS utilizes a sequential mechanism to AMPylate Rho GTPases. Discovery of a ternary reaction mechanism along with structural insight provides critical groundwork for future studies for the family of AMPylators that modify hydroxyl-containing residues with AMP.
Luong
Phi
P
Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Kinch
Lisa N
LN
Brautigam
Chad A
CA
Grishin
Nick V
NV
Tomchick
Diana R
DR
Orth
Kim
K
D000249:Adenosine Monophosphate / Q000378:metabolism*; D001426:Bacterial Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D001665:Binding Sites / Q000235:genetics; D002384:Catalysis; D018360:Crystallography, X-Ray; D054884:Host-Pathogen Interactions; D006801:Humans; D007700:Kinetics; D008958:Models, Molecular; D009154:Mutation; D009713:Nucleotidyltransferases / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D011485:Protein Binding; D017433:Protein Structure, Secondary; D017434:Protein Structure, Tertiary; D015398:Signal Transduction; D013912:Threonine / Q000235:genetics / Q000378:metabolism; D014735:Vibrio Infections / Q000378:metabolism / Q000382:microbiology; D014736:Vibrio parahaemolyticus / Q000378:metabolism* / Q000502:physiology; D020764:cdc42 GTP-Binding Protein / Q000378:metabolism; D020741:rho GTP-Binding Proteins / Q000235:genetics / Q000378:metabolism
D001426:Bacterial Proteins; D013912:Threonine; D000249:Adenosine Monophosphate; D009713:Nucleotidyltransferases; D020764:cdc42 GTP-Binding Protein; D020741:rho GTP-Binding Proteins
Curr Opin Microbiol. 2010 Feb;13(1):34-40
20071215
PLoS One. 2009 Jun 05;4(6):e5818
19503829
Nat Struct Biol. 2000 May;7(5):384-8
10802735
Biochemistry. 2000 Feb 29;39(8):2079-87
10684658
Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12497-502
18713860
Acta Crystallogr A. 1991 Mar 1;47 ( Pt 2):110-9
2025413
Infect Immun. 2008 May;76(5):2202-11
18347050
Science. 2009 Jan 9;323(5911):269-72
19039103
Mol Microbiol. 2009 Aug;73(4):639-49
19627496
Acta Crystallogr D Biol Crystallogr. 2006 Aug;62(Pt 8):859-66
16855301
Acta Crystallogr D Biol Crystallogr. 2002 Nov;58(Pt 11):1948-54
12393927
Lancet. 2003 Mar 1;361(9359):743-9
12620739
Infect Immun. 2006 Feb;74(2):1032-42
16428750
Nat Struct Biol. 1997 Sep;4(9):686-9
9302992
Nature. 2001 Nov 15;414(6861):325-9
11713534
Proteins. 2009 Apr;75(1):264-71
19127588
Acta Crystallogr D Biol Crystallogr. 1998 Jul 1;54(Pt 4):487-93
9761844
Nucleic Acids Res. 2007 Jul;35(Web Server issue):W375-83
17452350
Acta Crystallogr D Biol Crystallogr. 2002 Oct;58(Pt 10 Pt 2):1772-9
12351820
J Biol Chem. 2000 Jul 21;275(29):22048-55
10811654
Nature. 2006 Nov 30;444(7119):567-73
17136086
Mol Cell. 2009 Apr 10;34(1):93-103
19362538
Nat Chem Biol. 2009 Jun;5(6):378-9
19448605
Clin Microbiol Rev. 2007 Jan;20(1):39-48
17223622
Biochemistry. 2002 Aug 6;41(31):9863-72
12146952
J Biol Chem. 2004 Dec 17;279(51):53248-58
15485804
Nat Struct Biol. 1999 May;6(5):458-63
10331874
Microbiol Immunol. 2004;48(4):313-8
15107542